Please assess the completion status of the following clinical trial:

Trial Title: Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* type 2 diabetes mellitus diagnosed within the prior 2 months~* HbA1c \> 7% at the time of inclusion~* willing to perform intensive diabetes management~* able to comply with treatment and follow-up regimen~Exclusion Criteria:~* HbA1c \> 8% at time of randomization~* creatinine \> 1.5 mg/dl~* liver function tests \> 3 times the upper limit of normal~* severe anemia~* severe proliferative retinopathy~* NYHA class III or IV heart failure~* active CAD or recent (within 6 months) MI~* pregnant, willing to get pregnant, or not willing to practice any contraceptive method~* non-english speaking~* active heavy alcohol or illicit drug users (within past 6 months)~* history of lactic acidosis

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Metfomin and Insulin (Type: ACTIVE_COMPARATOR): Metformin 1000mg/BID and Insulin Novolog 70/30 per protocol titration
- Metformin, Pioglitazone and Glyburide (Type: ACTIVE_COMPARATOR): Metformin 1000mg/BID, Pioglitazone 45 mg and glyburide per protocol titration

Based on this trial design, predict the completion outcome and termination type (if applicable).